Europe Respiratory Care Devices Market Analysis
The Europe Respiratory Care Devices Market is entering a decisive growth phase, driven by an aging population, increasing respiratory disorders, technological innovation, and a strong shift toward home-based healthcare. According to Renub Research, the market is projected to rise from US$ 6.8 billion in 2024 to US$ 12.97 billion by 2033, expanding at a CAGR of 7.45% between 2025 and 2033.
This upward trajectory reflects not only growing clinical demand but also structural changes in healthcare delivery across Europe, where respiratory health management has become a strategic priority.
Download Free Sample Report:https://www.renub.com/request-sample-page.php?gturl=europe-respiratory-care-devices-market-p.php
Market Overview: The Rising Importance of Respiratory Care Devices
Respiratory care devices are medical instruments designed to diagnose, monitor, and treat breathing disorders. They are essential for managing chronic and acute conditions such as asthma, chronic obstructive pulmonary disease (COPD), sleep apnea, respiratory distress syndrome, cystic fibrosis, and acute infections.
Common respiratory care devices include:
- Mechanical ventilators
- Nebulizers
- Oxygen concentrators
- CPAP and BiPAP machines
- Pulse oximeters
- Spirometers
- Respiratory consumables and accessories
These devices are widely used in hospitals and clinics and are increasingly being adopted in homecare environments. Advancements in automation, portability, artificial intelligence integration, and cloud connectivity have significantly improved patient comfort, treatment adherence, and real-time monitoring capabilities.
The post-pandemic environment has further accelerated demand. COVID-19 heightened awareness about lung health and underscored the importance of respiratory infrastructure preparedness across Europe. Governments and healthcare institutions have since strengthened investment in respiratory equipment and long-term pulmonary care management.
Key Growth Drivers of the Europe Respiratory Care Devices Market
1. Rising Prevalence of Respiratory Diseases
One of the strongest growth catalysts is the growing incidence of respiratory illnesses across Europe. Conditions such as asthma, COPD, and obstructive sleep apnea continue to rise due to environmental pollution, smoking habits, urbanization, occupational hazards, and lifestyle changes.
For example, in Germany, asthma affects approximately 10% of children and 4–5% of adults. Across Europe, COPD remains one of the leading causes of morbidity and mortality. Sleep apnea is also increasingly diagnosed due to improved awareness and screening tools.
As the disease burden expands, the demand for:
- CPAP devices
- Nebulizers
- Oxygen concentrators
- Inhalers
- Monitoring systems
continues to grow. Healthcare systems are investing heavily in early diagnosis and long-term disease management, directly strengthening the respiratory care devices market.
2. Technological Advancements Transforming Patient Care
Technological innovation is reshaping the respiratory care ecosystem. Smart inhalers, AI-powered ventilators, connected spirometers, and cloud-based monitoring solutions are redefining patient engagement and disease management.
A notable example includes the collaboration between MAGNET GROUP and KoKo LLC in March 2022, enabling enhanced spirometry and lung function diagnostics through advanced software integration.
Telemedicine integration is another key development. Remote patient monitoring systems allow physicians to track respiratory parameters in real-time, reducing hospital visits and enabling early intervention. Portable oxygen concentrators and compact nebulizers are making home-based treatment more convenient and efficient.
These technological advancements improve:
- Patient compliance
- Data accuracy
- Treatment outcomes
- Healthcare efficiency
As digital healthcare expands across Europe, smart respiratory devices are expected to gain significant traction.
3. Aging Population Driving Long-Term Demand
Europe’s demographic shift is one of the most influential structural drivers of market growth. According to the European Commission, approximately 21.6% of the EU population—around 449.3 million people as of January 2024—is aged 65 or older.
Aging is directly associated with reduced lung capacity and increased susceptibility to chronic respiratory diseases. Older individuals are more prone to:
- COPD
- Asthma
- Sleep apnea
- Pulmonary fibrosis
This demographic trend fuels long-term demand for therapeutic and monitoring devices such as CPAP machines, portable oxygen concentrators, and nebulizers.
Additionally, elderly patients increasingly prefer homecare solutions over prolonged hospital stays. This shift strengthens demand for compact, easy-to-use respiratory devices tailored to home environments.
Market Challenges
Despite promising growth, the Europe Respiratory Care Devices Market faces notable challenges.
High Cost of Advanced Devices
Advanced respiratory equipment such as ventilators and portable oxygen systems often involve significant upfront and maintenance costs. This can limit accessibility, particularly in lower-income regions or among elderly individuals on fixed incomes.
Public healthcare systems, which dominate many European countries, face budget constraints. Procurement cycles may be delayed, and reimbursement limitations can slow device adoption.
Regulatory Complexities Under EU MDR
The implementation of the European Union Medical Device Regulation (MDR) has introduced stricter clinical evaluation, labeling, and post-market surveillance requirements.
While these regulations ensure safety and quality, they also increase compliance costs and approval timelines. Smaller manufacturers may face operational difficulties navigating the regulatory landscape, potentially slowing innovation and product launches.
Country-Level Insights
Germany
Germany represents one of Europe’s largest and most technologically advanced respiratory care markets. Growth is fueled by rising respiratory diseases and a rapidly aging population.
In March 2022, the Free State of Bavaria allocated EUR 225,000 to researchers at FAU and McGill University to develop a wearable breathing-monitoring device for patients with chronic respiratory conditions.
Key industry players operating in Germany include:
- Koninklijke Philips
- ResMed Inc
- Drägerwerk AG
Germany’s focus on digital health innovation and reimbursement-backed healthcare infrastructure continues to strengthen market growth.
France
France’s respiratory care market is expanding steadily due to high asthma prevalence and a mature healthcare system. According to a 2022 study published in PLOS One, France reports asthma prevalence of 13.5%, one of the highest in Europe.
The country is witnessing rising adoption of:
- Oxygen concentrators
- Nebulizers
- Portable respiratory devices
A strong hospital network combined with growing homecare demand is driving consistent expansion in therapeutic and monitoring equipment segments.
United Kingdom
The United Kingdom’s respiratory care market continues to grow amid increasing COPD, asthma, and sleep apnea cases. Technological advancements and safety-driven innovation are shaping product development.
In May 2022, Honeywell introduced two NIOSH-certified respiratory products, including the DC365 Small Surgical N95 Respirator, designed for healthcare workers requiring smaller sizing.
Additionally, Responsive Respiratory launched a new product catalog featuring advanced oxygen and PAP accessory cleaning solutions.
Leading companies such as:
- Medtronic Plc
- General Electric Company
- Masimo Corporation
are expanding respiratory care solutions across the UK through innovation and distribution partnerships.
Segmentation Analysis
By Application
- Chronic Obstructive Pulmonary Disease (COPD)
- Obstructive Sleep Apnea
- Asthma
- Respiratory Distress Syndrome
- Cystic Fibrosis
- Others
COPD and sleep apnea segments hold significant market share due to long-term management requirements and increasing diagnosis rates.
By Device Type
- Therapeutic Devices
- Monitoring Devices
- Diagnostic Devices
- Consumables & Accessories
Therapeutic devices dominate revenue contribution, while monitoring devices are growing rapidly due to digital health integration.
By Product Type
- Respiratory Consumables
- Nebulizers
- Oxygen Concentrators
- Polysomnography Devices
- Pulse Oximeters
- Mechanical Ventilators
- Spirometers
- Others
Oxygen concentrators and CPAP devices are expected to see substantial growth owing to chronic disease management trends.
By End Users
- Hospitals
- Home Care
- Ambulatory Care
Homecare is emerging as the fastest-growing segment, supported by telemedicine adoption and aging demographics.
Country-Wise Coverage
The report comprehensively analyzes France, Germany, Italy, Spain, the United Kingdom, Belgium, Netherlands, Russia, Poland, Greece, Norway, Romania, Portugal, and the Rest of Europe.
Competitive Landscape
The Europe Respiratory Care Devices Market remains moderately consolidated, with global and regional players competing through product innovation, strategic collaborations, and geographic expansion.
Major companies analyzed from four perspectives—overview, key persons, recent developments, and financial insights—include:
- Becton, Dickinson and Company
- Chart Industries Inc
- Getinge AB
These players are investing in AI integration, portable respiratory technologies, and digital health platforms to maintain competitive advantage.
Outlook: What Lies Ahead for 2025–2033?
The future of Europe’s respiratory care market is strongly tied to three macro trends:
- Chronic Disease Management Expansion
- Digital and Remote Healthcare Acceleration
- Home-Based Care Ecosystem Growth
With Renub Research forecasting the market to reach US$ 12.97 billion by 2033, sustained innovation and supportive healthcare policies will likely shape long-term growth.
As respiratory diseases continue to rise and Europe’s population ages, demand for advanced therapeutic and diagnostic solutions will remain strong. Simultaneously, regulatory frameworks and cost pressures will challenge manufacturers to innovate efficiently and maintain affordability.
Final Thoughts
The Europe Respiratory Care Devices Market stands at a pivotal moment. Rising respiratory disease prevalence, demographic shifts, and cutting-edge technology are driving steady and sustainable growth. While high device costs and regulatory hurdles present obstacles, ongoing innovation and healthcare modernization are expected to outweigh these challenges.
With a projected CAGR of 7.45% through 2033, the market reflects not just commercial expansion, but a broader commitment to improving respiratory health outcomes across Europe. Stakeholders that prioritize affordability, digital integration, and patient-centric solutions will be best positioned to capitalize on this dynamic and rapidly evolving landscape.
